Table 1:
Summary Table.
| Type of profiling | p53 status | # of unique cell lines | % cell lines w/ >100 genes deregulated (>2X) | % cell lines w/ p53 pathway activation | % cell lines w/ emergence or expansion of a p53 mutation (ΔAF>0.05) |
|---|---|---|---|---|---|
| Gene expression | WT | 43 | 44.2% | 32.6% | NA |
| Mutant | 122 | 43.4% | 9.1% | ||
| WB + RT-qPCR | WT | 5 | NA | 80% | NA |
| Mutant | 4 | 0% | |||
| Targeted DNA sequencing | WT | 14 | NA | NA | 10% |
| Mutant | 26 |
Shown are the number of TP53-WT and TP53-mutant cell lines that were included in each experimental assay, the % of cell lines with > 100 genes deregulated by > 2 fold-change (FC), the % of cell lines with significant activation of the p53 pathway, and % of cell lines with emergence or expansion of a functional TP53 mutation (ΔAF > 0.05).